EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression

Mohammed Saqif Ahmad, Maria Braoudaki, Shoib Sarwar Siddiqui iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0311212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Mohammed Saqif Ahmad und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Sialyltransferases, MicroRNAs, Disease Progression. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) has become a significant global health concern and ranks among the leading causes of morbidity and mortality worldwide. Due to its malignant nature, current immunotherapeutic treatments are used to tackle this issue. However, not all patients respond positively to treatment, thereby limiting clinical effectiveness and requiring the identification of novel therapeutic targets to optimise current strategies. The putative ligand of Siglec-15, Sialyl-Tn (STn), is associated with tumour progression and is synthesised by the sialyltransferases ST6GALNAC1 and ST6GALNAC2. However, the deregulation of both sialyltransferases within the literature remain limited, and the involvement of microRNAs (miRNAs) in STn production require further elucidation. Here, we identified miRNAs involved in the regulation of ST6GALNAC1 via a computational approach and further analysis of miRNA binding sites were determined. In silico tools predicted miR-21, miR-30e and miR-26b to regulate the ST6GALNAC1 gene, all of which had shown significant upregulated expression in the tumour cohort. Moreover, each miRNA displayed a high binding affinity towards the seed region of ST6GALNAC1 . Additionally, enrichment analysis outlined pathways associated with several cancer hallmarks, including epithelial to mesenchymal transition (EMT) and MYC targets associated with tumour progression. Furthermore, our in silico findings demonstrated that the ST6GALNAC1 expression profile was significantly downregulated in CRC tumours, and its low expression correlated with poor survival outcomes when compared with patient survival data. In comparison to its counterpart, there were no significant differences in the expression of ST6GALNAC2 between normal and malignant tissues, which was further evidenced in our immunohistochemistry analysis. Immunohistochemistry staining highlighted significantly higher expression was more prevalent in normal human tissues with regard to ST6GALNAC1 . In conclusion, the integrated in silico analysis highlighted that STn production is not reliant on deregulated sialyltransferase expression in CRC, and ST6GALNAC1 expression is regulated by several oncomirs. We proposed the involvement of other sialyltransferases in the production of the STn antigen and CRC progression via the Siglec-15/Sia axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsSialyltransferasesMicroRNAsDisease ProgressionGene Expression Regulation, NeoplasticHumansMaleFemaleCell Line, TumorClinical Relevancebeta-D-Galactoside alpha 2-6-SialyltransferaseAntigens, Tumor-Associated, CarbohydrateAntigens, CD

Substanzen

SialyltransferasesMicroRNAsgalactosyl-1-3-N-acetylgalactosaminyl-specific 2,6-sialyltransferasesialosyl-Tn antigenST6GAL1 protein, humanbeta-D-Galactoside alpha 2-6-SialyltransferaseAntigens, Tumor-Associated, CarbohydrateAntigens, CD

Autor:innen und Institutionen

  • School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.

ORCID-Profile: Shoib Sarwar Siddiqui

Zitieren

APA

Ahmad, M. S., Braoudaki, M., & Siddiqui, S. S. (2024). Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression. PLOS ONE. https://doi.org/10.1371/journal.pone.0311212

Vancouver

Ahmad MS, Braoudaki M, Siddiqui SS. Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression. PLOS ONE. 2024. doi:10.1371/journal.pone.0311212

BibTeX
@article{Ahmad2024,
  author = {Ahmad, Mohammed Saqif and Braoudaki, Maria and Siddiqui, Shoib Sarwar},
  title = {Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0311212}
}
Kostenlos starten →